Gentherm Reports 2026 Second Quarter Results and Announces a New Increased Stock Repurchase Authorization

Gentherm reports record Q2 2026 revenue, raises full-year guidance, announces $400M stock repurchase program, and expands medical portfolio.

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.